Antonio Federico: What are the aims of your ERN? Helen Cross: The objectives of the EpiCARE network will be: To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation.

A session on neurological palliative care was included within the 15th World Congress of the European Association for Palliative Care in Madrid on 18th May.  In 2016, a Memorandum of Understanding was signed between the EAPC and the EAN and… Continue Reading

Palliative care has featured again at a session at the 3rd Congress of the European Academy of Neurology in Amsterdam at the end of June 2017.  There has been a developing collaboration between the EAN and the EAPC and in… Continue Reading

ntonio Federico: What are the aims of your ERN? Teresinha Evangelista: Our MISSION: Through collaborative cross-border work the EURO-NMD ERN will improve the lives of EU citizens by improving diagnosis, treatment and the delivery of high-quality, accessible and cost-effective healthcare to patients with rare Neuromuscular Diseases (NMD) requiring a particular concentration of resources or expertise.

The EAN Rare neurological diseases task force will be holding its 1st teaching course under the auspices of Dafin F. Muresanu, Professor of Neurology at the “Iuliu Hatieganu” University of Medicine and Pharmacy, in Cluj-Napoca, Romania. This teaching course aims… Continue Reading

by Antonella Macerollo The first Summer School on Neuromodulation for Movement Disorders was sponsored by the European Section of Movement Disorders (MDS) and took place in Grenoble, France, on July 6-8th 2017. This three-day course encompassed several key lectures from… Continue Reading

After a very successful congress in Amsterdam with more than 6000 participants, the Editors-in-chief, Elena Moro and Tim von Oertzen interviewed the two persons, responsible for the organisation of the congress, Prof. Paul Boon, chair EAN programme committee and Prof.… Continue Reading

The new CME article August 2017: “Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies – a national cohort study” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer… Continue Reading

Following the the very well attended lunch session: “Challenges for women in neurology”  Elena Moro and Selma Tromp invited the 3 lecturing ladies for a round-talbe discussion.                       Please read the enitre report on this session, or the follow-up article… Continue Reading

During the EAN conference in Amsterdam in June 2017, the symposium on "Challenges for Women in Neurology" had 2 out of 3 invited speakers address aspects African Neurology (Dekker from Tanzania; Charway-Felli from Ghana). That is not a coincidence, as this region has seen significant developments in very recent years.

or August 2017, we have selected: The Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:505-512. There is evidence that oxidative stress induced by free radicals is a key factor of progression in amyotrophic lateral sclerosis (ALS).

During the 3rd Congress of the EAN, an outstanding opportunity of meeting colleagues who took part in previous Spring School meetings was organized.

Residents and research fellows discover the VUmc This year’s annual hospital visit on Sunday 25th of June 2017 brought 80 residents and research fellows from all over the world to the impressive VU University Medical Center Amsterdam (VUmc) located in the southwestern part of Amsterdam, close to the campus of VU University. The RRFS hospital visit was organised in collaboration with the Dutch Junior Neurology Association.